These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 229020
1. Rat brain and lung cyclic nucleotide phosphodiesterases: different responses to cromoglycate [proceedings]. Saeed SA, Butt NM, Taylor WA. Biochem Soc Trans; 1979 Oct; 7(5):1037-8. PubMed ID: 229020 [No Abstract] [Full Text] [Related]
2. Inhibitory effects of cromoglycate and theophylline on rat macrophage and mast-cell cyclic nucleotide phosphodiesterase [proceedings]. Saeed SA, Butt NM, Sheldon D, Taylor WA. Biochem Soc Trans; 1979 Dec; 7(6):1304-6. PubMed ID: 231532 [No Abstract] [Full Text] [Related]
3. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain. Singh R, Shankar R. Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810 [No Abstract] [Full Text] [Related]
4. Cyclic nucleotide phosphodiesterases from rat pancreas: differential regulation by a calcium-dependent activator protein [proceedings]. Vandermeers A, Vandermeers MC, Rathe J, Delforge A, Christophe J. Biochem Soc Trans; 1977 Jan; 5(4):981-2. PubMed ID: 199510 [No Abstract] [Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats. Sharma RV, Bhalla RC. Biochim Biophys Acta; 1978 Oct 12; 526(2):479-88. PubMed ID: 214127 [No Abstract] [Full Text] [Related]
6. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes. Perez de Gracia B, Rhoads AR, West WL. Experientia; 1980 Jul 15; 36(7):824-5. PubMed ID: 6249634 [Abstract] [Full Text] [Related]
8. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications. Hidaka H, Endo T. Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Jul 15; 16():245-59. PubMed ID: 6144253 [No Abstract] [Full Text] [Related]
9. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts. Epstein PM, Hachisu R. Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Jul 15; 16():303-24. PubMed ID: 6202124 [No Abstract] [Full Text] [Related]
14. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system. Strada SJ, Martin MW, Thompson WJ. Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Oct 01; 16():13-29. PubMed ID: 6326518 [No Abstract] [Full Text] [Related]
17. Drosophila cyclic nucleotide phosphodiesterases. Davis RL, Kauvar LM. Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Oct 01; 16():393-402. PubMed ID: 6326533 [No Abstract] [Full Text] [Related]
18. Adenylate cyclase and cyclic nucleotide phosphodiesterases in the developing rat liver. Sicard RE, Aprille JR. Biochim Biophys Acta; 1977 Dec 22; 500(2):235-45. PubMed ID: 201294 [No Abstract] [Full Text] [Related]
20. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases. Kuo JF, Shoji M, Brackett NL, Helfman DM. J Cyclic Nucleotide Res; 1978 Dec 22; 4(6):463-74. PubMed ID: 85641 [Abstract] [Full Text] [Related] Page: [Next] [New Search]